官方服务：
资源简介：
Treatment-related adverse events.
应用场景：
创建时间：
2017-12-29
相关数据集
Adverse events in patients taking macrolide antibiotics versus placebo for any indication: Supplementary data set B
Supplementary data B Any reported adverse event that occurred in less than 5% of any group – grouped under the primary System Organ Class, according to the MedDRA coding system.
Research Data Australia80
Safety and tolerability of high-dose ulinastatin after 2-hour intravenous infusion in adult healthy Chinese volunteers: A randomized, double-blind, placebo-controlled, ascending-dose study
Ulinastatin, is a broad-spectrum protease inhibitor purified from human urine, inhibits endogenous proteases such as trypsin, α-chymotrypsin, hyaluronidase, and plasmin. It is widely being used at inc
NIAID Data Ecosystem60
Correlations between frequency of adverse events reported and patient safety culture.
Correlations between frequency of adverse events reported and patient safety culture.
Figshare2022-10-19 更新50
Number of patients (total = 57) with clinical adverse effects (chi-square test with Yates correction).
Number of patients (total = 57) with clinical adverse effects (chi-square test with Yates correction).
NIAID Data Ecosystem60
Disproportionality Analysis of Fondaparinux-Associated Adverse Events Based on the FDA Adverse Event Reporting System (FAERS)
This dataset contains the minimal underlying data used to reproduce the findings of the study titled “Safety profile of fondaparinux based on the FAERS database: a disproportionality analysis”. The da
DataCite Commons2025-11-16 更新60
